YOUR GO-TO INTELLIGENCE RESOURCE FOR THE SCHOLARLY PUBLISHING INDUSTRY

NEJM Group, publisher of the New England Journal of Medicine, has announced the launch of its newest title, NEJM AI, a peer-reviewed, monthly journal dedicated to the latest research and application of artificial intelligence (AI) and machine learning in medicine. In addition to original research articles, the journal publishes reviews, policy perspectives and educational material for clinicians, scientists, healthcare leaders, policy makers, regulators, and executives with pharmaceutical, device-manufacturing and technology companies. Benchmark data sets and protocols are a unique feature of the journal and are freely available to practitioners to help with testing and advancing medical AI knowledge.

In the past decade, the Food and Drug Administration has approved AI-powered devices capable of reading medical imaging and assisting clinicians in making diagnoses. While many of these devices and programs meet regulatory standards, the medical community has been slow to see the potential of AI medical applications or adopt them. NEJM AI aims to be an essential resource for medical professionals who want an in-depth understanding of how breakthrough clinical applications in AI/ML will be evaluated to inform clinical practice.

According to Statista, the market for AI in healthcare in 2021 was $11 billion (USD) worldwide, with that number expected to reach $188 billion by 2030.

Community members are encouraged to listen to NEJM AI Grand Rounds, a podcast hosted by deputy editors Dr. Arjun (Raj) Manrai and Dr. Andrew Beam featuring informal conversations with experts exploring issues at the intersection of artificial intelligence, machine learning, and medicine. The journal also hosts virtual events to open dialogue around the value, ethics, and quality of medical AI.

NEJM AI will provide a range of perspectives on the critical ethical and legal challenges and risks around the development and deployment of AI in a clinical setting. Stimulating conversations among clinicians who use medical AI, developers of the technology, and patients who benefit from these applications is the mission of NEJM AI.